Your browser doesn't support javascript.
loading
Racial differences in hepatitis C treatment eligibility.
Melia, Michael T; Muir, Andrew J; McCone, Jonathan; Shiffman, Mitchell L; King, John W; Herrine, Steven K; Galler, Greg W; Bloomer, Joseph R; Nunes, Frederick A; Brown, Kimberly A; Mullen, Kevin D; Ravendhran, Natarajan; Ghalib, Reem H; Boparai, Navdeep; Jiang, Ruiyun; Noviello, Stephanie; Brass, Clifford A; Albrecht, Janice K; McHutchison, John G; Sulkowski, Mark S.
Affiliation
  • Melia MT; Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. mmelia4@jhmi.edu
Hepatology ; 54(1): 70-8, 2011 Jul.
Article in En | MEDLINE | ID: mdl-21488082
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepatitis C / Black People / White People / Eligibility Determination Type of study: Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Hepatology Year: 2011 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepatitis C / Black People / White People / Eligibility Determination Type of study: Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Hepatology Year: 2011 Type: Article Affiliation country: United States